362
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials*

, &
Pages 2089-2101 | Accepted 22 May 2008, Published online: 10 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Per-Olof Thuresson, Bart Heeg, Benedicte Lescrauwaet, Karin Sennfält, Annette Alaeus & Aljoscha Neubauer. (2011) Cost-effectiveness of atazanavir/ritonavir compared with lopinavir/ritonavir in treatment-naïve human immunodeficiency virus-1 patients in Sweden. Scandinavian Journal of Infectious Diseases 43:4, pages 304-312.
Read now
S.J. Thurston, B. Heeg, F. de Charro & B. van Hout. (2010) Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial. Current Medical Research and Opinion 26:3, pages 641-651.
Read now

Articles from other publishers (14)

Péter Elek, András Harsányi, Tamás Zelei, Kata Csetneki & Zoltán Kaló. (2017) Policy objective of generic medicines from the investment perspective: The case of clopidogrel. Health Policy 121:5, pages 558-565.
Crossref
Meng-Shen Tong, Pei-Hsun Sung, Chu-Feng Liu, Kuan-Hung Chen, Sheng-Ying Chung, Sarah Chua, Chien-Jen Chen, Wei-Chieh Lee, Han-Tan Chai, Hon-Kan Yip & Hsueh-Wen Chang. (2017) Impact of Double Loading Regimen of Clopidogrel on Final Angiographic Results, Incidence of Upper Gastrointestinal Bleeding and Clinical Outcomes in Patients with STEMI Undergoing Primary Coronary Intervention. International Heart Journal 58:5, pages 686-694.
Crossref
Maximilian H. M. Hatz, Reiner Leidl, Nichola A. Yates & Björn Stollenwerk. (2014) A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. PharmacoEconomics 32:4, pages 377-393.
Crossref
William S. Weintraub, Leonid Mandel & Sandra A. Weiss. (2013) Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations. PharmacoEconomics 31:11, pages 959-970.
Crossref
Danny Liew, Richard De Abreu Lourenço, Michael Adena, Lesley Chim & Philip Aylward. (2013) Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes. Clinical Therapeutics 35:8, pages 1110-1117.e9.
Crossref
Fatemeh Moheimani & Denise E. Jackson. (2012) P2Y12 receptor: platelet thrombus formation and medical interventions. International Journal of Hematology 96:5, pages 572-587.
Crossref
Georgia Kourlaba, Vassilis Fragoulakis & Nikos Maniadakis. (2012) Clopidogrel versus Aspirin in Patients with Atherothrombosis. Applied Health Economics and Health Policy 10:5, pages 331-342.
Crossref
Georgia Kourlaba, Vassilis Fragoulakis & Nikos Maniadakis. (2012) Clopidogrel versus Aspirin in Patients with Atherothrombosis. Applied Health Economics and Health Policy 10:5, pages 331-342.
Crossref
Chad Kessler, Kurian Thomas & John Kao. (2023) Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome, Transient Ischemic Attack, and Noncardioembolic Stroke in an Era of Cost Containment. Journal of Investigative Medicine 60:5, pages 792-800.
Crossref
Monika Scheuringer, Narine Sahakyan, Karl J Krobot & Volker Ulrich. (2012) Cost of clinical events in health economic evaluations in Germany: a systematic review. Cost Effectiveness and Resource Allocation 10:1, pages 7.
Crossref
Can Yücel Karabay, Mehmet Mustafa Can, Ibrahim Halil Tanboğa, Güler Ahmet, Atila Bitigen & Victor Serebruany. (2011) Recurrent Acute Stent Thrombosis Due to Allergic Reaction Secondary to Clopidogrel Therapy. American Journal of Therapeutics 18:4, pages e119-e122.
Crossref
P. De Rango, G. Parlani, L. Romano, F. Verzini, G. Giordano, E. Cieri, M. Barbante & P. Cao. (2011) Second-generation Thienopyridine use is not Associated with Better Early Perioperative Outcome During Carotid Stenting. European Journal of Vascular and Endovascular Surgery 41:2, pages 214-221.
Crossref
J. Floris S. Logman, Bart M.S. Heeg, Johan Herlitz & Ben A. van Hout. (2010) Costs and Consequences of Clopidogrel versus Aspirin for Secondary Prevention of Ischaemic Events in (High-Risk) Atherosclerotic Patients in Sweden. Applied Health Economics and Health Policy 8:4, pages 251-265.
Crossref
Roberto Ravasio. (2013) Valutazione economica della terapia con tienopiridine in pazienti sottoposti a impianto di stent coronarico a rilascio di farmaco dopo infarto miocardico acutoEconomic evaluation of thienopyridine therapy in patient with drug eluting stent placement after acute myocardial infarction. Giornale Italiano di Health Technology Assessment 3:1, pages 41-48.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.